Circulating endothelial markers and probability of stroke in haemodialysis patients [3]

Blood Coagulation and Fibrinolysis

Volumn 14, Issue 3, 2003, Pages 315-317

  Borawski, Jacek ^a   Naumnik, Beata ^a   Myśliwiec, Michał ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; THROMBOMODULIN; VON WILLEBRAND FACTOR;

ADULT; AGED; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; DIALYSIS; ENDOTHELIUM CELL; FEMALE; HEMODIALYSIS; HUMAN; HYPERTENSION; KIDNEY FAILURE; LETTER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROBABILITY; RISK FACTOR; STROKE; THROMBOSIS;

ADULT; AGED; BIOLOGICAL MARKERS; CEREBROVASCULAR ACCIDENT; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROBABILITY; RENAL DIALYSIS; VON WILLEBRAND FACTOR;

EID: 0038057358     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200304000-00018     Document Type: Letter

References (12)

1. Blann AD, McCollum CN, Lip GYH. Relationship between plasma markers of endothelial cell integrity and the Framingham cardiovascular disease risk-factor scores in apparently healthy individuals. Blood Coagul Fibrinolysis 2002; 13: 513-518.
2. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32: S112-S119.
3. Zoccali C. Cardiovascular risk in uraemic patients - is it fully explained by classical risk factors? Nephrol Dial Transplant 2000; 15: 454-457.
4. Borawski J, Naumnik B, Pawlak K, Myśliwiec M. Soluble thrombomodulin is associated with viral hepatitis, blood pressure, and medications in haemodialysis patients. Nephrol Dial Transplant 2001; 16: 787-792.
5. Borawski J, Naumnik B, Pawlak K, Myśliwiec M. Endothelial dysfunction marker von Willebrand factor antigen in haemodialysis patients: associations with pre-dialysis blood pressure and acute phase response. Nephrol Dial Transplant 2001; 16: 1442-1447.
6. Borawski J, Pawlak K, Myśliwiec M. Inflammatory markers and platelet aggregation tests as predictors of hemoglobin and endogenous erythropoietin levels in hemodialysis patients. Nephron 2002; 91: 671-681.
7. Shah HH, Chow AO, Mattana J. Stroke in patients undergoing dialysis. Int J Artif Organs 2000; 23: 77-82.
8. Wilson PWF. Risk of stroke calculator. UpToDate on CD-ROM, vol 10, number 2. Wellesley, MA: UpToDate Inc.; 2002.
9. Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke 1991; 22: 312-318.
10. Zager PG, Nikolic J, Brown RH, Campbell MA, Hunt WC, Peterson D, et al. 'U' curve association of blood pressure and mortality in hemodialysis patients. Kidney Int 1998; 54: 561-569.
11. Port FK, Hulbert-Shearon TE, Wolfe RA, Bloembergen WE, Golper TA, Agodoa LY, et al. Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis 1999; 33: 507-517.
12. Foley RN, Herzog CA, Collins AJ. Blood pressure and long-term mortality in United States: USRDS Waves 3 and 4 Study. Kidney Int 2002; 62: 1784-1790.